All Stories

  1. Drugs Targeting the Canonical NF-κB Pathway to Treat Viral and Autoimmune Myocarditis

    Article • Current Pharmaceutical Design, January 2016, Bentham Science Publishers

    Dr Alan Valaperti

  2. The adapter protein c-Cbl-associated protein (CAP) protects from acute CVB3-mediated myocarditis through stabilization of type I interferon production and reduced cytotoxicity

    Article • Basic Research in Cardiology, April 2014, Springer Science + Business Media

    Professor Urs Eriksson, Dr Alan Valaperti

  3. Vaccination with Flt3L-induced CD8α+ dendritic cells prevents CD4+ T helper cell-mediated experimental autoimmune myocarditis

    Article • Vaccine, October 2013, Elsevier

    Dr Alan Valaperti, Professor Urs Eriksson

  4. Innate Immune Interleukin-1 Receptor–Associated Kinase 4 Exacerbates Viral Myocarditis by Reducing CCR5 + CD11b + Monocyte Migration and Impairing Interferon Production

    Article • Circulation, October 2013, Wolters Kluwer Health

    Professor Urs Eriksson, Dr Alan Valaperti

  5. The role of IL-17 in experimental autoimmune myocarditis

    Article • January 2009, Springer Science + Business Media

    Professor Urs Eriksson, Dr Alan Valaperti

  6. CD11b+ Monocytes Abrogate Th17 CD4+ T Cell-Mediated Experimental Autoimmune Myocarditis

    Article • The Journal of Immunology, February 2008, The American Association of Immunologists

    Professor Urs Eriksson, Dr Alan Valaperti